United States Cholesterol Medicines Market Report 2017

August 2017 | 99 pages | ID: UDE5A1601B0EN
QYResearch

Abstracts

In this report, the United States Cholesterol Medicines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Cholesterol Medicines in these regions, from 2012 to 2022 (forecast).

United States Cholesterol Medicines market competition by top manufacturers/players, with Cholesterol Medicines sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Pfizer Inc
• Eli Lilly and Company
• Abbott Laboratories
• Merck & Co
• Bristol-Myers Squibb Company
• AstraZeneca
• Amgen Inc
• Novartis AG
• GlaxoSmithKline
• Regeneron Pharmaceuticals

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Oral
• Injection

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Cholesterol Medicines for each application, including

• Cardiovascular Diseases
• Liver Disease
• Heart Disease
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Cholesterol Medicines Market Report 2017

1 CHOLESTEROL MEDICINES OVERVIEW

1.1 Product Overview and Scope of Cholesterol Medicines
1.2 Classification of Cholesterol Medicines by Product Category
  1.2.1 United States Cholesterol Medicines Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Cholesterol Medicines Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Oral
  1.2.4 Injection
1.3 United States Cholesterol Medicines Market by Application/End Users
  1.3.1 United States Cholesterol Medicines Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Cardiovascular Diseases
  1.3.3 Liver Disease
  1.3.4 Heart Disease
  1.3.5 Others
1.4 United States Cholesterol Medicines Market by Region
  1.4.1 United States Cholesterol Medicines Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Cholesterol Medicines Status and Prospect (2012-2022)
  1.4.3 Southwest Cholesterol Medicines Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Cholesterol Medicines Status and Prospect (2012-2022)
  1.4.5 New England Cholesterol Medicines Status and Prospect (2012-2022)
  1.4.6 The South Cholesterol Medicines Status and Prospect (2012-2022)
  1.4.7 The Midwest Cholesterol Medicines Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Cholesterol Medicines (2012-2022)
  1.5.1 United States Cholesterol Medicines Sales and Growth Rate (2012-2022)
  1.5.2 United States Cholesterol Medicines Revenue and Growth Rate (2012-2022)

2 UNITED STATES CHOLESTEROL MEDICINES MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Cholesterol Medicines Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Cholesterol Medicines Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Cholesterol Medicines Average Price by Players/Suppliers (2012-2017)
2.4 United States Cholesterol Medicines Market Competitive Situation and Trends
  2.4.1 United States Cholesterol Medicines Market Concentration Rate
  2.4.2 United States Cholesterol Medicines Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Cholesterol Medicines Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES CHOLESTEROL MEDICINES SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Cholesterol Medicines Sales and Market Share by Region (2012-2017)
3.2 United States Cholesterol Medicines Revenue and Market Share by Region (2012-2017)
3.3 United States Cholesterol Medicines Price by Region (2012-2017)

4 UNITED STATES CHOLESTEROL MEDICINES SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Cholesterol Medicines Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Cholesterol Medicines Revenue and Market Share by Type (2012-2017)
4.3 United States Cholesterol Medicines Price by Type (2012-2017)
4.4 United States Cholesterol Medicines Sales Growth Rate by Type (2012-2017)

5 UNITED STATES CHOLESTEROL MEDICINES SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Cholesterol Medicines Sales and Market Share by Application (2012-2017)
5.2 United States Cholesterol Medicines Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES CHOLESTEROL MEDICINES PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Pfizer Inc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Cholesterol Medicines Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pfizer Inc Cholesterol Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Eli Lilly and Company
  6.2.2 Cholesterol Medicines Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Eli Lilly and Company Cholesterol Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Abbott Laboratories
  6.3.2 Cholesterol Medicines Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Abbott Laboratories Cholesterol Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Merck & Co
  6.4.2 Cholesterol Medicines Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Merck & Co Cholesterol Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Bristol-Myers Squibb Company
  6.5.2 Cholesterol Medicines Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Bristol-Myers Squibb Company Cholesterol Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 AstraZeneca
  6.6.2 Cholesterol Medicines Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 AstraZeneca Cholesterol Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Amgen Inc
  6.7.2 Cholesterol Medicines Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Amgen Inc Cholesterol Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Novartis AG
  6.8.2 Cholesterol Medicines Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Novartis AG Cholesterol Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 GlaxoSmithKline
  6.9.2 Cholesterol Medicines Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 GlaxoSmithKline Cholesterol Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Regeneron Pharmaceuticals
  6.10.2 Cholesterol Medicines Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Regeneron Pharmaceuticals Cholesterol Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 CHOLESTEROL MEDICINES MANUFACTURING COST ANALYSIS

7.1 Cholesterol Medicines Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Cholesterol Medicines

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Cholesterol Medicines Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Cholesterol Medicines Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES CHOLESTEROL MEDICINES MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Cholesterol Medicines Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Cholesterol Medicines Sales Volume Forecast by Type (2017-2022)
11.3 United States Cholesterol Medicines Sales Volume Forecast by Application (2017-2022)
11.4 United States Cholesterol Medicines Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Cholesterol Medicines
Figure United States Cholesterol Medicines Market Size (K Units) by Type (2012-2022)
Figure United States Cholesterol Medicines Sales Volume Market Share by Type (Product Category) in 2016
Figure Oral Product Picture
Figure Injection Product Picture
Figure United States Cholesterol Medicines Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Cholesterol Medicines by Application in 2016
Figure Cardiovascular Diseases Examples
Table Key Downstream Customer in Cardiovascular Diseases
Figure Liver Disease Examples
Table Key Downstream Customer in Liver Disease
Figure Heart Disease Examples
Table Key Downstream Customer in Heart Disease
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Cholesterol Medicines Market Size (Million USD) by Region (2012-2022)
Figure The West Cholesterol Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Cholesterol Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Cholesterol Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Cholesterol Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Cholesterol Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Cholesterol Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Cholesterol Medicines Sales (K Units) and Growth Rate (2012-2022)
Figure United States Cholesterol Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Cholesterol Medicines Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Cholesterol Medicines Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Cholesterol Medicines Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Cholesterol Medicines Sales Share by Players/Suppliers
Figure 2017 United States Cholesterol Medicines Sales Share by Players/Suppliers
Figure United States Cholesterol Medicines Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Cholesterol Medicines Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Cholesterol Medicines Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Cholesterol Medicines Revenue Share by Players/Suppliers
Figure 2017 United States Cholesterol Medicines Revenue Share by Players/Suppliers
Table United States Market Cholesterol Medicines Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Cholesterol Medicines Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Cholesterol Medicines Market Share of Top 3 Players/Suppliers
Figure United States Cholesterol Medicines Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Cholesterol Medicines Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Cholesterol Medicines Product Category
Table United States Cholesterol Medicines Sales (K Units) by Region (2012-2017)
Table United States Cholesterol Medicines Sales Share by Region (2012-2017)
Figure United States Cholesterol Medicines Sales Share by Region (2012-2017)
Figure United States Cholesterol Medicines Sales Market Share by Region in 2016
Table United States Cholesterol Medicines Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Cholesterol Medicines Revenue Share by Region (2012-2017)
Figure United States Cholesterol Medicines Revenue Market Share by Region (2012-2017)
Figure United States Cholesterol Medicines Revenue Market Share by Region in 2016
Table United States Cholesterol Medicines Price (USD/Unit) by Region (2012-2017)
Table United States Cholesterol Medicines Sales (K Units) by Type (2012-2017)
Table United States Cholesterol Medicines Sales Share by Type (2012-2017)
Figure United States Cholesterol Medicines Sales Share by Type (2012-2017)
Figure United States Cholesterol Medicines Sales Market Share by Type in 2016
Table United States Cholesterol Medicines Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Cholesterol Medicines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Cholesterol Medicines by Type (2012-2017)
Figure Revenue Market Share of Cholesterol Medicines by Type in 2016
Table United States Cholesterol Medicines Price (USD/Unit) by Types (2012-2017)
Figure United States Cholesterol Medicines Sales Growth Rate by Type (2012-2017)
Table United States Cholesterol Medicines Sales (K Units) by Application (2012-2017)
Table United States Cholesterol Medicines Sales Market Share by Application (2012-2017)
Figure United States Cholesterol Medicines Sales Market Share by Application (2012-2017)
Figure United States Cholesterol Medicines Sales Market Share by Application in 2016
Table United States Cholesterol Medicines Sales Growth Rate by Application (2012-2017)
Figure United States Cholesterol Medicines Sales Growth Rate by Application (2012-2017)
Table Pfizer Inc Basic Information List
Table Pfizer Inc Cholesterol Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Inc Cholesterol Medicines Sales Growth Rate (2012-2017)
Figure Pfizer Inc Cholesterol Medicines Sales Market Share in United States (2012-2017)
Figure Pfizer Inc Cholesterol Medicines Revenue Market Share in United States (2012-2017)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Cholesterol Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly and Company Cholesterol Medicines Sales Growth Rate (2012-2017)
Figure Eli Lilly and Company Cholesterol Medicines Sales Market Share in United States (2012-2017)
Figure Eli Lilly and Company Cholesterol Medicines Revenue Market Share in United States (2012-2017)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Cholesterol Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Laboratories Cholesterol Medicines Sales Growth Rate (2012-2017)
Figure Abbott Laboratories Cholesterol Medicines Sales Market Share in United States (2012-2017)
Figure Abbott Laboratories Cholesterol Medicines Revenue Market Share in United States (2012-2017)
Table Merck & Co Basic Information List
Table Merck & Co Cholesterol Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck & Co Cholesterol Medicines Sales Growth Rate (2012-2017)
Figure Merck & Co Cholesterol Medicines Sales Market Share in United States (2012-2017)
Figure Merck & Co Cholesterol Medicines Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb Company Basic Information List
Table Bristol-Myers Squibb Company Cholesterol Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Company Cholesterol Medicines Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Company Cholesterol Medicines Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb Company Cholesterol Medicines Revenue Market Share in United States (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Cholesterol Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Cholesterol Medicines Sales Growth Rate (2012-2017)
Figure AstraZeneca Cholesterol Medicines Sales Market Share in United States (2012-2017)
Figure AstraZeneca Cholesterol Medicines Revenue Market Share in United States (2012-2017)
Table Amgen Inc Basic Information List
Table Amgen Inc Cholesterol Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Inc Cholesterol Medicines Sales Growth Rate (2012-2017)
Figure Amgen Inc Cholesterol Medicines Sales Market Share in United States (2012-2017)
Figure Amgen Inc Cholesterol Medicines Revenue Market Share in United States (2012-2017)
Table Novartis AG Basic Information List
Table Novartis AG Cholesterol Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis AG Cholesterol Medicines Sales Growth Rate (2012-2017)
Figure Novartis AG Cholesterol Medicines Sales Market Share in United States (2012-2017)
Figure Novartis AG Cholesterol Medicines Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Cholesterol Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Cholesterol Medicines Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Cholesterol Medicines Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Cholesterol Medicines Revenue Market Share in United States (2012-2017)
Table Regeneron Pharmaceuticals Basic Information List
Table Regeneron Pharmaceuticals Cholesterol Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Regeneron Pharmaceuticals Cholesterol Medicines Sales Growth Rate (2012-2017)
Figure Regeneron Pharmaceuticals Cholesterol Medicines Sales Market Share in United States (2012-2017)
Figure Regeneron Pharmaceuticals Cholesterol Medicines Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cholesterol Medicines
Figure Manufacturing Process Analysis of Cholesterol Medicines
Figure Cholesterol Medicines Industrial Chain Analysis
Table Raw Materials Sources of Cholesterol Medicines Major Players/Suppliers in 2016
Table Major Buyers of Cholesterol Medicines
Table Distributors/Traders List
Figure United States Cholesterol Medicines Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Cholesterol Medicines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Cholesterol Medicines Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Cholesterol Medicines Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Cholesterol Medicines Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Cholesterol Medicines Sales Volume (K Units) Forecast by Type in 2022
Table United States Cholesterol Medicines Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Cholesterol Medicines Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Cholesterol Medicines Sales Volume (K Units) Forecast by Application in 2022
Table United States Cholesterol Medicines Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Cholesterol Medicines Sales Volume Share Forecast by Region (2017-2022)
Figure United States Cholesterol Medicines Sales Volume Share Forecast by Region (2017-2022)
Figure United States Cholesterol Medicines Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources